• Aspira Women's Health entered a subordinated secured term loan with Agile Lending as lead lender, dated July 1, 2026.
• Promissory note principal USD 1.05 million; scheduled maturity Jan. 26, 2027; total interest charges USD 441,000 if paid on time.
• Loan is subordinated to all senior indebtedness; secured by a lien on substantially all personal property, including IP.
• Proceeds earmarked to refinance January debt, fund general corporate purposes.
• Financing statements to perfect security interests generally limited to default; lenders can accelerate, enforce remedies, repossess collateral upon default.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspira Women's Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000926617-26-000052), on July 15, 2026, and is solely responsible for the information contained therein.